October 15th, 2026Pathological Response Does Not Reliably Predict Survival in SarcomaInconsistent definitions limit pathological response as a soft tissue sarcoma marker, according to a narrative review.Read more
October 14th, 2026Iberdomide Regimen Cuts RRMM Progression Risk by 51%, Trial FindsThese phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.Read more
October 16th, 2026Genetic Analysis Links Insomnia Liability to Higher Inflammation MarkerGenetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.Read more
October 16th, 2026AJMC® in the Press, October 16, 2026Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.Read more
October 16th, 2026Medicaid Gender Care Rule May Face Uphill Legal BattleAlice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.Read more
October 16th, 2026Proinflammatory Diets Linked to Higher MASLD, MetALD MortalityProinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.Read more
October 15th, 2026Autoimmune Hepatitis Regimens Carry Distinct Adverse Event SignalsAn analysis finds distinct adverse event reporting patterns across immunosuppressive regimens, highlighting the need for tailored safety monitoring.Read more
October 15th, 2026FAQ: How Payers Can Close HIV Prevention and PrEP Access GapsOn National Latinx AIDS Awareness Day, experts outline HIV prevention gaps in Hispanic communities and how payers can ease PrEP access.Read more